HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.

AbstractBACKGROUND:
It has been established that defective nef genes and differences in the Nef-mediated downmodulation of CD4 and MHC-I cell surface expression can be associated with different rates of HIV-1 disease progression.
OBJECTIVE:
To evaluate whether nef alleles derived from perinatally HIV-1-infected children showing no, slow or rapid disease progression differ in their abilities to downmodulate mature MHC-II or to upregulate the invariant chain (Ii) associated with immature MHC-II complexes.
METHODS:
Nef alleles derived from HIV-1-infected children were cloned into expression vectors and proviral HIV-1 constructs co-expressing Nef and enhanced green fluorescence protein via an internal ribosomal entry site. Nef-mediated modulation of CD4, MHC-I, MHC-II or Ii surface expression was analysed by flow cytometric analysis of Jurkat T cells, monocytic THP-1 cells, CD4 T cells and macrophages transduced with vesicular stomatitis virus G-pseudotyped HIV-1 nef variants or transiently transfected HeLa class II transactivator cells.
RESULTS:
: Nef alleles derived from HIV-1-infected children with non-progressive infection were significantly more active in the upregulation of Ii and downregulation of MHC-II than those derived from rapid progressors.
CONCLUSION:
Nef alleles particularly active in interfering with MHC-II antigen presentation are more frequently found in perinatally HIV-1-infected non-progressors than rapid progressors. Possibly in the context of an immature host immune system, strongly impaired MHC-II function might contribute to lower levels of immune activation and a decelerated loss of CD4 T cells.
AuthorsMichael Schindler, Steffen Wildum, Nicoletta Casartelli, Margherita Doria, Frank Kirchhoff
JournalAIDS (London, England) (AIDS) Vol. 21 Issue 9 Pg. 1103-7 (May 31 2007) ISSN: 0269-9370 [Print] England
PMID17502720 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Differentiation, B-Lymphocyte
  • Antigens, Viral
  • CD4 Antigens
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
  • invariant chain
Topics
  • Acquired Immunodeficiency Syndrome (genetics, immunology)
  • Antigens, Differentiation, B-Lymphocyte (genetics)
  • Antigens, Viral (genetics, immunology)
  • CD4 Antigens (genetics)
  • CD4-Positive T-Lymphocytes (immunology)
  • Down-Regulation (genetics)
  • Gene Expression Regulation, Viral (genetics)
  • Genes, nef (genetics)
  • HIV Infections (genetics, immunology)
  • HIV Long-Term Survivors
  • HIV-1 (genetics)
  • HeLa Cells
  • Histocompatibility Antigens Class I (genetics, immunology)
  • Histocompatibility Antigens Class II (genetics, immunology)
  • Humans
  • Infant, Newborn
  • Jurkat Cells
  • Lymphocyte Activation (genetics)
  • Up-Regulation (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: